Stereotaxis, Inc.
AMEX: STXS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange Arca
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- David L. Fischel
- Employees
- 135
- Headquarters
- St. Louis, United States
- IPO year
- 2004
- Market cap
- $173.0M
- Website
- https://www.stereotaxis.com
Loading STXS…
Loading profile data…Frequently asked questions about STXS
What does Stereotaxis, Inc. (STXS) do?
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Mod...
Where does STXS trade?
Stereotaxis, Inc. (STXS) trades on the New York Stock Exchange Arca.
What sector is STXS in?
Stereotaxis, Inc. (STXS) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of Stereotaxis, Inc.?
David L. Fischel is the chief executive officer of Stereotaxis, Inc. (STXS).
Where is Stereotaxis, Inc. headquartered?
Stereotaxis, Inc. is headquartered in United States.
Does STXS pay a dividend?
Stereotaxis, Inc. (STXS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did STXS go public?
Stereotaxis, Inc. (STXS) completed its initial public offering in 2004.